69 10) Information des professionnels de santé, 69 11) Interactions médicamenteuses contre-indiquées, p.69 ,
73 IV . Les résultats du second questionnaire : pas d' amélioration significative, p.74 ,
76 1) Les médecins traitants (généralistes et cardiologues), p.76 ,
79 3) Les documents accessibles sur, p.79 ,
Hospitalisation pour iatrogénie médicamenteuse au sein du service de cardiologie du CH de Saint-Dié, Thèse : Médecine : Faculté de Médecine de Nancy, p.30, 2004. ,
Les cliniques d' anticoagulants: 1' expérience toulousaine. Tribumed 2001, disponible sur le site http://www.tribumed.com. Dernière consultation le 23 septembre, 2004. ,
Impact of Adherence, Knowledge, and Quality of Life on Anticoagulation Control, Annals of Pharmacotherapy, vol.40, issue.4, pp.632-638, 2005. ,
DOI : 10.1177/014107680309600405
Determinants of Compliance with Anticoagulation: A Case-Control Study, The American Journal of Medicine, vol.103, issue.1, pp.1-1, 1997. ,
DOI : 10.1016/S0002-9343(97)90048-6
Utilisation des AVIS en pratique médicale courante, STV, issue.12, pp.26-39, 2000. ,
Anticoagulation orale en pratique g??riatrique, La Revue de M??decine Interne, vol.24, issue.2, pp.107-108, 2003. ,
DOI : 10.1016/S0248-8663(02)00020-6
Antivitamine K et extraction dentaire, La Revue Prescrire, vol.253, pp.615-623, 2004. ,
Fiche de transparence AVK Disponible sur le site Internet, 2005. ,
Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation, International Journal of Cardiology, vol.99, issue.1, pp.37-45, 2005. ,
DOI : 10.1016/j.ijcard.2003.11.008
Les cliniques d' anticoagulants, STV, vol.15, pp.288-90, 2003. ,
The Pharmacology and Management of the Vitamin K Antagonists, Chest, vol.126, issue.3, pp.204-237, 2004. ,
DOI : 10.1378/chest.126.3_suppl.204S
Bleeding and Thromboembolism During Anticoagulant Therapy:A Population-Based Study in Rochester, Minnesota, Mayo Clinic Proceedings, vol.70, issue.8, pp.725-758, 1995. ,
DOI : 10.4065/70.8.725
Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT), The Lancet, vol.348, issue.9025, pp.423-431, 1996. ,
DOI : 10.1016/S0140-6736(96)01109-9
A Multicomponent Intervention To Prevent Major Bleeding Complications in Older Patients Receiving Warfarin, Annals of Internal Medicine, vol.133, issue.9, pp.687-95, 2000. ,
DOI : 10.7326/0003-4819-133-9-200011070-00010
An Analysis of the Lowest Effective Intensity of Prophylactic Anticoagulation for Patients with Nonrheumatic Atrial Fibrillation, New England Journal of Medicine, vol.335, issue.8 ,
DOI : 10.1056/NEJM199608223350802
Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation, IV Engl J Med, vol.349, pp.101-110, 2003. ,
Comparison of low-intensity warfarin therapy with conventionnal-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism, N Engl J Med, vol.349, pp.63-64, 2003. ,
Hemorrhagic Complications of Anticoagulant Treatment, Chest, vol.126, issue.3, pp.287-290, 2003. ,
DOI : 10.1378/chest.126.3_suppl.287S
Anticoagulant-related bleeding:clinical epidemiology, prediction, and prevention, Am J Med, vol.95, pp.3-15, 1993. ,
DOI : 10.1016/0002-9343(93)90285-w
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin ??????Access the ???Journal Club??? discussion of this paper at http://www.elsevier.com/locate/ajmselect/, The American Journal of Medicine, vol.105, issue.2, pp.91-100, 1998. ,
DOI : 10.1016/S0002-9343(98)00198-3
Major haemorrhagic complications during oral anticoagulant therapy in a Danish Population-based cohort, Journal of Internal Medicine, vol.305, issue.6, pp.497-503, 1997. ,
DOI : 10.1136/bmj.305.6867.1457
Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy, The American Journal of Medicine, vol.87, issue.2, pp.144-52, 1989. ,
DOI : 10.1016/S0002-9343(89)80689-8
Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin, Annals of Internal Medicine, vol.120, issue.11, pp.897-902, 1994. ,
DOI : 10.7326/0003-4819-120-11-199406010-00001
Les accidents hémorragiques des antivitamines K en médecine interne : étude rétrospective sur 72 patients, Rev Med Interne, vol.22, issue.1, p.149, 2001. ,
Risk factors for complications of chronic anticoagulation : a multicenter study. Warfarin Optimized Outpatient Follow-up Study Group, Ann Intern Med, vol.118, pp.51-52, 1993. ,
Bleeding risk factors in chronjc oral anticoagulation with acenocoumarol, Am J, vol.63, pp.192-198, 2000. ,
on behalf of the ISCOAT Study Group Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding: a multicenter inception cohort study, Thromb Haemost, vol.85, pp.41-49, 2001. ,
Characteristics of an anticoagulant therapy and comorbidity related to overanticoagulation, Thromb Haemost, vol.86, pp.569-574, 2001. ,
81 ème édition. Issy-les-moulinaux :éditions VIDAL, 2005. ,
Prediction of the Risk of Bleeding During Anticoagulant Treatment for Venous Thromboembolism, Archives of Internal Medicine, vol.159, issue.5, pp.457-60, 1999. ,
DOI : 10.1001/archinte.159.5.457
Anticoagulation and pregnancy, European Heart Journal, vol.16, issue.10, pp.13-17, 1995. ,
DOI : 10.1093/oxfordjournals.eurheartj.a060738
Qualité du suivi sur le long terme des traitements anticoagulants oraux, Arch Mal Coeur Vaiss, vol.98, pp.199-204, 2005. ,
Impact d???un programme d?????ducation th??rapeutique sur les attitudes de pr??vention vis-??-vis du risque iatrog??ne : ??tude pilote contr??l??e visant les patients sous anticoagulants oraux pour maladie thromboembolique veineuse, Journal des Maladies Vasculaires, vol.29, issue.3, pp.152-160, 2004. ,
DOI : 10.1016/S0398-0499(04)96737-6
Traitement anticoagulant et éducation du patient : une nécessité, STV, vol.11, pp.647-52, 1999. ,
Consensus guidelines for coordinated outpatients oral anticoagulation therapy management. Anticoagulation Guidelines Task Force, Ann pharmacother, vol.3, issue.1, pp.604-619, 1997. ,
DOI : 10.1177/106002809703100516
Comparison of an Anticoagulation Clinic With Usual Medical Care, Archives of Internal Medicine, vol.158, issue.15, pp.164-165, 1998. ,
DOI : 10.1001/archinte.158.15.1641
Les centres de suivi et de conseil des traitements anticoagulants??: un outil pour diminuer le nombre de complications h??morragiques des antivitamines K, La Revue de M??decine Interne, vol.24, issue.2, pp.75-82, 2003. ,
DOI : 10.1016/S0248-8663(02)00019-X
Assessment of patient capability to self-adjust oral anticoagulant dose : a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK), Haematologica, vol.85, pp.826-829, 2000. ,
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison, The Lancet, vol.356, issue.9224, pp.97-102, 2000. ,
DOI : 10.1016/S0140-6736(00)02470-3
A Structured Teaching and Self-management Program for Patients Receiving Oral Anticoagulation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>, JAMA, vol.281, issue.2, pp.145-50, 1999. ,
DOI : 10.1001/jama.281.2.145
Improvement of prognosis by home prothrombin estimation in patient with life-long anticoagulant therapy, Eur Heart J, vol.17, p.230, 1996. ,
International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous?, The Annals of Thoracic Surgery, vol.72, issue.1, pp.44-52, 2001. ,
DOI : 10.1016/S0003-4975(01)02656-X
Home prothrombin time monitoring after the initiation ofwarfarin therapy, Ann Intern Med, vol.1, issue.1, pp.730-737, 1989. ,
DOI : 10.7326/0003-4819-111-9-730
Long-term patients self-management of oral anticoagulation, Arch Intern Med, vol.155, pp.2-185, 1995. ,
Outcome analysis of a pharmacist-managed anticoagulation service, Pharmacotherapy, vol.15, pp.732-741, 1995. ,
Accuracy of laboratory and portable monitor INR determination, Arch Intern Med, vol.155, pp.1-861, 1995. ,
DOI : 10.1001/archinte.1995.00430170053006
Optimal frequency of patient monitoring and intensity of oral anticoagulation therapy in valvular heart disease, Journal of Thrombosis and Thrombolysis, vol.5, issue.suppl, pp.19-24, 1998. ,
DOI : 10.1023/A:1013228718768
Patient self-management of oral anticoagulant care vs. management by specialized anticoagulation clinics: positive effects on quality of life, Journal of Thrombosis and Haemostasis, vol.25, issue.4, pp.584-91, 2004. ,
DOI : 10.1037//0022-006X.70.3.459
Diabetes education and insulin therapy: when will they ever learn?, Journal of Internal Medicine, vol.12, issue.Suppl 1, pp.321-327, 1993. ,
DOI : 10.1111/j.1365-2796.1993.tb00679.x
European Concerted Action on anticoagulation. Multicentre randomised study of computerised anticoagulant dosage, Lancet, vol.352, pp.1505-1514, 1998. ,
Vers des anticoagulants plus actifs et plus sûrs, Concours Med, vol.124, pp.24-25, 2002. ,
SPORTIF Executive Steering Committee For the SPORTIF V Investigators. Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial, JAMA, vol.293, pp.690-698, 2005. ,